The drug discovery company Implexion Pharma and researchers from Lund University have explored new potential drug candidates for type 2 diabetes using X-ray crystallography research techniques at MAX IV.
09
May
MAX IV research contributes to the development of new cancer drugs
In the battle against cancer, scientists from the drug discovery company Sprint Bioscience and researchers from MAX IV have taken important steps together toward developing new and more efficient cancer drugs with the help of fragment screening by X-ray crystallography.
Tetra Pak commences first-of-its-kind sustainability research at MAX IV
The newest research station at MAX IV, ForMAX, has hosted its first industry experiment: A ground-breaking study on fibre-based sustainable food packaging, performed by Tetra Pak in collaboration with Chalmers University of Technology.
Global tool company studies wear behaviour of TiAlN coating using X-rays
Metal cutting tool company Seco Tools and researchers from Linköping University have studied structural changes in TiAlN coatings on tools in atomic detail at the MAX IV beamline Balder. The results will guide the company’s development of more efficient metal-cutting tools.
01
Feb
ForMAX beamline is now open for experiments
ForMAX, the newest beamline at MAX IV, is now officially open for experiments. The focus will be research on new, sustainable materials from the forest, but the beamline will also be useful for research in many other fields and industries, including food, textiles, and life science.
Creating tastier vegan cheese using synchrotron X-rays
The quest for tastier, more sustainable vegan cheese has led Swedish food company Cassius AB to take a closer look at cheese protein structures. Using synchrotron X-rays at MAX IV, Cassius are searching for the perfect scientific recipe for plant-based cheese.
30
Nov
Developing next generation biostimulants using synchrotron X-rays
Arevo, a company known for producing environmentally friendly solutions for improved plant establishment and growth, has performed its first experiment at MAX IV. The research is focused on developing a new line of biostimulant products with a unique nutrient release profile, ensuring beneficial long-term effects for both plants and soils.